Researchers find marker for urothelial cancer:
This article was originally published in Clinica
Executive Summary
Measuring the level of a protein called angiogenin in tumour tissue and serum of patients with urothelial carcinoma could help doctors determine their prognosis. The mean level of angiogenin expression was four times higher in invasive urothelial carcinomas than in superficial carcinomas and five times higher than in normal tissue, a Canadian and Japanese research team revealed in the July issue of Cancer.